AmerisourceBergen Corporation Logo

AmerisourceBergen Corporation

ABC

(2.0)
Stock Price

179,98 USD

3.61% ROA

248.02% ROE

21.56x PER

Market Cap.

36.149.702.920,00 USD

544.52% DER

0.81% Yield

0.69% NPM

AmerisourceBergen Corporation Stock Analysis

AmerisourceBergen Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

AmerisourceBergen Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (555.31%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

3 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

4 ROA

The stock's ROA (3.61%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (39.5x) suggests it's overvalued, potentially making it an expensive investment.

7 DER

The stock is burdened with a heavy load of debt (545%), making it financially unstable and potentially risky for investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-16.140), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

AmerisourceBergen Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

AmerisourceBergen Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

AmerisourceBergen Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

AmerisourceBergen Corporation Revenue
Year Revenue Growth
1994 4.301.800.000
1995 4.668.900.000 7.86%
1996 5.551.700.000 15.9%
1997 7.815.900.000 28.97%
1998 8.668.800.000 9.84%
1999 9.807.400.000 11.61%
2000 11.645.021.000 15.78%
2001 16.191.353.000 28.08%
2002 45.234.794.000 64.21%
2003 49.657.328.000 8.91%
2004 53.178.954.000 6.62%
2005 54.577.321.000 2.56%
2006 61.203.145.000 10.83%
2007 66.074.312.000 7.37%
2008 70.189.733.000 5.86%
2009 71.759.990.000 2.19%
2010 77.953.979.000 7.95%
2011 80.217.558.000 2.82%
2012 79.489.596.000 -0.92%
2013 87.959.167.000 9.63%
2014 119.569.127.000 26.44%
2015 135.961.803.000 12.06%
2016 146.849.686.000 7.41%
2017 153.143.826.000 4.11%
2018 167.939.635.000 8.81%
2019 179.589.121.000 6.49%
2020 189.893.926.000 5.43%
2021 213.988.843.000 11.26%
2022 238.587.006.000 10.31%
2023 275.689.324.000 13.46%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

AmerisourceBergen Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

AmerisourceBergen Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

AmerisourceBergen Corporation EBITDA
Year EBITDA Growth
1994 272.400.000
1995 107.900.000 -152.46%
1996 109.500.000 1.46%
1997 133.900.000 18.22%
1998 194.900.000 31.3%
1999 208.700.000 6.61%
2000 216.731.000 3.71%
2001 307.592.000 29.54%
2002 833.494.000 63.1%
2003 967.769.000 13.87%
2004 994.878.000 2.72%
2005 843.985.000 -17.88%
2006 841.252.000 -0.32%
2007 931.834.000 9.72%
2008 950.524.000 1.97%
2009 974.429.000 2.45%
2010 1.193.296.000 18.34%
2011 1.319.449.000 9.56%
2012 1.445.430.000 8.72%
2013 1.174.063.000 -23.11%
2014 1.399.465.000 16.11%
2015 1.597.670.000 12.41%
2016 2.186.417.000 26.93%
2017 2.420.002.000 9.65%
2018 2.084.219.000 -16.11%
2019 2.487.756.000 16.22%
2020 2.426.248.000 -2.54%
2021 3.408.797.000 28.82%
2022 3.474.757.000 1.9%
2023 3.140.704.000 -10.64%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

AmerisourceBergen Corporation Gross Profit
Year Gross Profit Growth
1994 243.300.000
1995 268.800.000 9.49%
1996 304.900.000 11.84%
1997 389.300.000 21.68%
1998 423.100.000 7.99%
1999 475.600.000 11.04%
2000 520.892.000 8.7%
2001 700.118.000 25.6%
2002 2.024.474.000 65.42%
2003 2.247.159.000 9.91%
2004 2.179.182.000 -3.12%
2005 1.980.184.000 -10.05%
2006 2.231.815.000 11.27%
2007 2.326.739.000 4.08%
2008 2.047.002.000 -13.67%
2009 2.100.075.000 2.53%
2010 2.356.642.000 10.89%
2011 2.539.096.000 7.19%
2012 2.669.098.000 4.87%
2013 2.507.819.000 -6.43%
2014 2.982.366.000 15.91%
2015 3.529.313.000 15.5%
2016 4.272.606.000 17.4%
2017 4.546.002.000 6.01%
2018 4.612.317.000 1.44%
2019 5.138.312.000 10.24%
2020 5.191.884.000 1.03%
2021 6.943.228.000 25.22%
2022 8.296.367.000 16.31%
2023 9.013.808.000 7.96%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

AmerisourceBergen Corporation Net Profit
Year Net Profit Growth
1994 -207.700.000
1995 10.200.000 2136.27%
1996 35.500.000 71.27%
1997 45.400.000 21.81%
1998 50.500.000 10.1%
1999 67.500.000 25.19%
2000 99.014.000 31.83%
2001 125.102.000 20.85%
2002 344.941.000 63.73%
2003 441.229.000 21.82%
2004 468.390.000 5.8%
2005 319.199.000 -46.74%
2006 467.714.000 31.75%
2007 469.167.000 0.31%
2008 250.559.000 -87.25%
2009 503.397.000 50.23%
2010 636.748.000 20.94%
2011 706.624.000 9.89%
2012 718.986.000 1.72%
2013 433.707.000 -65.78%
2014 276.484.000 -56.87%
2015 -134.887.000 304.97%
2016 1.427.929.000 109.45%
2017 414.484.000 -244.51%
2018 1.658.405.000 75.01%
2019 855.365.000 -93.88%
2020 -3.399.558.000 125.16%
2021 1.539.932.000 320.76%
2022 1.698.820.000 9.35%
2023 1.402.260.000 -21.15%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

AmerisourceBergen Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1994 -5
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 1 0%
2002 1 0%
2003 1 0%
2004 1 100%
2005 1 0%
2006 1 100%
2007 1 0%
2008 1 0%
2009 2 100%
2010 2 50%
2011 3 0%
2012 3 0%
2013 2 -100%
2014 1 0%
2015 -1 0%
2016 7 100%
2017 2 -500%
2018 8 85.71%
2019 4 -75%
2020 -17 125%
2021 7 328.57%
2022 8 12.5%
2023 7 -33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

AmerisourceBergen Corporation Free Cashflow
Year Free Cashflow Growth
1994 75.500.000
1995 -49.300.000 253.14%
1996 24.300.000 302.88%
1997 -25.200.000 196.43%
1998 115.500.000 121.82%
1999 -12.800.000 1002.34%
2000 199.961.000 106.4%
2001 -63.367.000 415.56%
2002 471.767.000 113.43%
2003 264.261.000 -78.52%
2004 635.803.000 58.44%
2005 1.323.262.000 51.95%
2006 694.133.000 -90.64%
2007 1.089.853.000 36.31%
2008 599.760.000 -81.71%
2009 637.926.000 5.98%
2010 923.989.000 30.96%
2011 999.994.000 7.6%
2012 1.141.408.000 12.39%
2013 585.675.000 -94.89%
2014 1.198.696.000 51.14%
2015 3.688.794.000 67.5%
2016 2.713.881.000 -35.92%
2017 1.022.610.000 -165.39%
2018 1.074.977.000 4.87%
2019 2.033.801.000 47.14%
2020 1.837.363.000 -10.69%
2021 2.228.369.000 17.55%
2022 2.206.770.000 -0.98%
2023 169.900.000 -1198.86%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

AmerisourceBergen Corporation Operating Cashflow
Year Operating Cashflow Growth
1994 84.000.000
1995 -35.600.000 335.96%
1996 40.000.000 189%
1997 -9.300.000 530.11%
1998 125.900.000 107.39%
1999 3.000.000 -4096.67%
2000 216.580.000 98.61%
2001 -40.004.000 641.4%
2002 535.926.000 107.46%
2003 354.815.000 -51.04%
2004 825.081.000 57%
2005 1.526.638.000 45.95%
2006 807.265.000 -89.11%
2007 1.207.904.000 33.17%
2008 737.069.000 -63.88%
2009 783.763.000 5.96%
2010 1.108.624.000 29.3%
2011 1.167.948.000 5.08%
2012 1.305.449.000 10.53%
2013 788.125.000 -65.64%
2014 1.463.153.000 46.14%
2015 3.920.379.000 62.68%
2016 3.178.497.000 -23.34%
2017 1.489.007.000 -113.46%
2018 1.411.388.000 -5.5%
2019 2.344.023.000 39.79%
2020 2.207.040.000 -6.21%
2021 2.666.586.000 17.23%
2022 2.703.088.000 1.35%
2023 169.900.000 -1490.99%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

AmerisourceBergen Corporation Capital Expenditure
Year Capital Expenditure Growth
1994 8.500.000
1995 13.700.000 37.96%
1996 15.700.000 12.74%
1997 15.900.000 1.26%
1998 10.400.000 -52.88%
1999 15.800.000 34.18%
2000 16.619.000 4.93%
2001 23.363.000 28.87%
2002 64.159.000 63.59%
2003 90.554.000 29.15%
2004 189.278.000 52.16%
2005 203.376.000 6.93%
2006 113.132.000 -79.77%
2007 118.051.000 4.17%
2008 137.309.000 14.03%
2009 145.837.000 5.85%
2010 184.635.000 21.01%
2011 167.954.000 -9.93%
2012 164.041.000 -2.39%
2013 202.450.000 18.97%
2014 264.457.000 23.45%
2015 231.585.000 -14.19%
2016 464.616.000 50.16%
2017 466.397.000 0.38%
2018 336.411.000 -38.64%
2019 310.222.000 -8.44%
2020 369.677.000 16.08%
2021 438.217.000 15.64%
2022 496.318.000 11.71%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

AmerisourceBergen Corporation Equity
Year Equity Growth
1994 -300.700.000
1995 -135.700.000 -121.59%
1996 -36.800.000 -268.75%
1997 14.300.000 357.34%
1998 75.300.000 81.01%
1999 166.300.000 54.72%
2000 282.294.000 41.09%
2001 2.838.564.000 90.06%
2002 3.316.338.000 14.41%
2003 4.005.317.000 17.2%
2004 4.339.045.000 7.69%
2005 4.280.357.000 -1.37%
2006 4.141.157.000 -3.36%
2007 3.099.720.000 -33.6%
2008 2.710.045.000 -14.38%
2009 2.716.469.000 0.24%
2010 2.954.297.000 8.05%
2011 2.868.965.000 -2.97%
2012 2.456.712.000 -16.78%
2013 2.319.745.000 -5.9%
2014 1.956.899.000 -18.54%
2015 633.520.000 -208.89%
2016 2.129.404.000 70.25%
2017 2.114.461.000 -0.71%
2018 3.167.098.000 33.24%
2019 3.107.495.000 -1.92%
2020 -660.348.000 570.58%
2021 584.411.000 212.99%
2022 -6.952.000 8506.37%
2023 666.287.000 101.04%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

AmerisourceBergen Corporation Assets
Year Assets Growth
1994 711.600.000
1995 838.700.000 15.15%
1996 1.188.000.000 29.4%
1997 1.745.000.000 31.92%
1998 1.552.300.000 -12.41%
1999 2.060.600.000 24.67%
2000 2.458.567.000 16.19%
2001 10.291.245.000 76.11%
2002 11.213.012.000 8.22%
2003 12.040.125.000 6.87%
2004 11.654.003.000 -3.31%
2005 11.381.174.000 -2.4%
2006 12.783.920.000 10.97%
2007 12.310.064.000 -3.85%
2008 12.217.786.000 -0.76%
2009 13.572.740.000 9.98%
2010 14.434.843.000 5.97%
2011 14.982.671.000 3.66%
2012 15.444.126.000 2.99%
2013 18.918.638.000 18.37%
2014 21.532.183.000 12.14%
2015 27.736.157.000 22.37%
2016 33.589.687.000 17.43%
2017 35.316.470.000 4.89%
2018 37.669.838.000 6.25%
2019 39.171.980.000 3.83%
2020 43.947.863.000 10.87%
2021 57.337.805.000 23.35%
2022 56.560.616.000 -1.37%
2023 62.558.746.000 9.59%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

AmerisourceBergen Corporation Liabilities
Year Liabilities Growth
1994 1.012.300.000
1995 974.400.000 -3.89%
1996 1.224.800.000 20.44%
1997 1.730.700.000 29.23%
1998 1.477.000.000 -17.18%
1999 1.894.300.000 22.03%
2000 2.176.273.000 12.96%
2001 7.452.681.000 70.8%
2002 7.896.674.000 5.62%
2003 8.034.808.000 1.72%
2004 7.314.958.000 -9.84%
2005 7.100.817.000 -3.02%
2006 8.642.763.000 17.84%
2007 9.210.344.000 6.16%
2008 9.507.741.000 3.13%
2009 10.856.271.000 12.42%
2010 11.480.546.000 5.44%
2011 12.113.706.000 5.23%
2012 12.987.414.000 6.73%
2013 16.598.893.000 21.76%
2014 19.575.284.000 15.2%
2015 27.102.637.000 27.77%
2016 31.460.283.000 13.85%
2017 33.202.009.000 5.25%
2018 34.619.877.000 4.1%
2019 36.178.774.000 4.31%
2020 44.787.499.000 19.22%
2021 56.753.394.000 21.08%
2022 56.489.343.000 -0.47%
2023 61.892.459.000 8.73%

AmerisourceBergen Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1257.36
Net Income per Share
8.35
Price to Earning Ratio
21.56x
Price To Sales Ratio
0.14x
POCF Ratio
11.21
PFCF Ratio
12.95
Price to Book Ratio
39.5
EV to Sales
0.16
EV Over EBITDA
11.33
EV to Operating CashFlow
12.24
EV to FreeCashFlow
14.25
Earnings Yield
0.05
FreeCashFlow Yield
0.08
Market Cap
36,15 Bil.
Enterprise Value
39,78 Bil.
Graham Number
29.26
Graham NetNet
-172.19

Income Statement Metrics

Net Income per Share
8.35
Income Quality
1.93
ROE
5.55
Return On Assets
0.03
Return On Capital Employed
0.2
Net Income per EBT
0.79
EBT Per Ebit
0.86
Ebit per Revenue
0.01
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.03
Operating Profit Margin
0.01
Pretax Profit Margin
0.01
Net Profit Margin
0.01

Dividends

Dividend Yield
0.01
Dividend Yield %
0.81
Payout Ratio
0.23
Dividend Per Share
1.46

Operating Metrics

Operating Cashflow per Share
16.06
Free CashFlow per Share
13.8
Capex to Operating CashFlow
-0.14
Capex to Revenue
-0
Capex to Depreciation
-0.6
Return on Invested Capital
0.34
Return on Tangible Assets
0.04
Days Sales Outstanding
29.83
Days Payables Outstanding
64.99
Days of Inventory on Hand
25.03
Receivables Turnover
12.23
Payables Turnover
5.62
Inventory Turnover
14.58
Capex per Share
-2.26

Balance Sheet

Cash per Share
6,87
Book Value per Share
4,56
Tangible Book Value per Share
-66.73
Shareholders Equity per Share
4.56
Interest Debt per Share
25.9
Debt to Equity
5.45
Debt to Assets
0.08
Net Debt to EBITDA
1.03
Current Ratio
0.88
Tangible Asset Value
-13,50 Bil.
Net Current Asset Value
-19,27 Bil.
Invested Capital
5.45
Working Capital
-5,80 Bil.
Intangibles to Total Assets
0.24
Average Receivables
20,14 Bil.
Average Payables
43,24 Bil.
Average Inventory
16903792500
Debt to Market Cap
0.14

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

AmerisourceBergen Corporation Dividends
Year Dividends Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 2 100%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 100%
2016 1 0%
2017 1 0%
2018 2 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 0%
2023 1 0%

AmerisourceBergen Corporation Profile

About AmerisourceBergen Corporation

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

CEO
Mr. Steven H. Collis
Employee
46.000
Address
1 West First Avenue
Conshohocken, 19428-1800

AmerisourceBergen Corporation Executives & BODs

AmerisourceBergen Corporation Executives & BODs
# Name Age
1 Mr. Lazarus Krikorian
Senior Vice President, Chief Accounting Officer & Corporation Controller
70
2 Bennett S. Murphy
Senior Vice President of Investor Relations
70
3 Ms. Kathy H. Gaddes
Executive Vice President & Chief Compliance Officer
70
4 Ms. Elizabeth S. Campbell
Executive Vice President & Chief Legal Officer
70
5 Mr. John G. Chou
Executive Vice President and Special Advisor to the Chairman & Chief Executive Officer
70
6 Mr. Steven H. Collis
Chairman, Pres & Chief Executive Officer
70
7 Mr. James F. Cleary Jr.
Executive Vice President & Chief Financial Officer
70
8 Dr. Robert P. Mauch Ph.D., PharmD
Executive Vice President & Chief Operating Officer
70
9 Ms. Gina K. Clark
Executive Vice President and Chief Communications & Admin. Officer
70
10 Ms. Silvana Battaglia
Executive Vice President & Chief HR Officer
70

AmerisourceBergen Corporation Competitors